SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-367183
Filing Date
2015-11-05
Accepted
2015-11-05 07:12:34
Documents
3
Period of Report
2015-10-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d79005d8k.htm 8-K 15693
2 EX-99.1 d79005dex991.htm EX-99.1 63457
3 GRAPHIC g79005ex99_1logo.jpg GRAPHIC 12027
  Complete submission text file 0001193125-15-367183.txt   97454
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 151198761
SIC: 2834 Pharmaceutical Preparations